On March 17, 2023, Robert Ruffolo resigned as a director of Aridis Pharmaceuticals, Inc. (the Company). Following more than six years of service to the Company, Dr. Ruffolo is retiring for personal family reasons and from being a director on other boards that he served on.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0575 USD | -4.17% | +1.77% | -17.97% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.97% | 2.88M | |
+7.56% | 111B | |
+11.37% | 106B | |
-12.39% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.79% | 16.81B | |
+38.14% | 12.54B | |
-24.38% | 8.09B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals, Inc. Announces the Resignation of Robert Ruffolo as Director